Filing Flows › Insulet (PODD) › Gross margin
Insulet (PODD) gross margin by quarter
Insulet's gross margin was 75.1% in Q3 2026 (third quarter 2026), +4.9 pts from Q2 2026. Over the last 7 quarters it ranged from 69.5% (Q1 2026) to 75.1% (Q3 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 75.1% | +4.9 pts | +2.8 pts |
| Q2 2026 | 70.2% | +0.7 pts | +0.5 pts |
| Q1 2026 | 69.5% | -3.1 pts | -2.4 pts |
| Q4 2025 | 72.5% | +0.3 pts | — |
| Q3 2025 | 72.2% | +2.6 pts | — |
| Q2 2025 | 69.7% | -2.2 pts | — |
| Q1 2025 | 71.9% | — | — |
Q3 2026 at a glance
Insulet, Q3 2026: revenue $842M (+19% year over year), operating margin 22.5%, net earnings $141M, operating cash flow $124M. The chart follows the revenue to costs, profit and cash.
Questions
What is Insulet's gross margin?
Insulet's gross margin was 75.1% in Q3 2026 (third quarter 2026), +4.9 pts from Q2 2026.
How has Insulet's gross margin changed?
Over the last 7 quarters it ranged from 69.5% (Q1 2026) to 75.1% (Q3 2026).